Published on 24 May 2022
Description:
In June’s PharmaTimes we stand on the precipice of healthcare change and focus on major developments across the pharmaverse. Our cover story looks at the metamorphosising anatomy of the new NHS and how it effects pharma. We feature the rapid growth and influence of data, the intriguing future of genomic medicine and the growing transparency which is yielding so many pharma partnerships.
Categories:
PharmaTimes28 articles from this collection:
Cover
2 - PharmaTimes Marketer of the Year
3 - From the editor
This month PharmaTimes presents Alantra’s annual ranking of the fastest growing pharma companies in the UK, and again there is much cause for celebration. As the analysis shows, a relentless focus on innovation and a determination to solve problems hindering patient outcomes are key traits that have helped those at the top shine in a sector that saw average growth of 33% in 2020. Taking top-spot in the ranking, Exscientia has almost quadrupled its revenue in the last two years, a remarkable achievement and even more so considering the current climate. Turn to page 20 for an in-depth look at the other companies reaching new heights and what’s fuelling their success.
4-5 - Contents
6 - Treatments
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on the potential reclassification of two progestogen-only, oral contraceptive pills containing desogestrel: Lovima 75mcg and Hana 75mcg film-coated tablets.
7 - Covid News
8 - Collaboration
9 - Conditions
10-11 - COVER STORY: Anatomy of the new NHS
12-13 - SUSTAINABILITY: Jolly green giants?
14-15 - PARTNERSHIPS: Run like clockwork
16 - BOBI Awards 2022
17 - COMMUNIQUE AWARDS
18 - Adverts
19 - CLINICAL TRIALS: About a revolution
20-21 - CLEAN DATA: Drive time
22-23 - LEADERSHIP: Room with a view
24-25 - HISTORY: It’s 100 Years of E. coli!
26-27 - PATIENT EXPERIENCE: Life changer
28-29 - MEDICINE: Taking flight
30 - AI: Show real
31 - YOUNG LEADERS
32-33 - SUSTAINABILITY: Cane and able
34-35 - Your moves
36-37 - DISEASE: Mind over matter
38 - FUTURE PHARMA: Gene genies
39 - FLYPHARMA
40 - MOY2022
PharmaTimes
PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.